These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 23466456)

  • 1. BMP4 reverses multidrug resistance through modulation of BCL-2 and GDNF in glioblastoma.
    Liu B; Chen Q; Tian D; Wu L; Dong H; Wang J; Ji B; Zhu X; Cai Q; Wang L; Zhang S
    Brain Res; 2013 Apr; 1507():115-24. PubMed ID: 23466456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis.
    Ku MC; Wolf SA; Respondek D; Matyash V; Pohlmann A; Waiczies S; Waiczies H; Niendorf T; Synowitz M; Glass R; Kettenmann H
    Acta Neuropathol; 2013 Apr; 125(4):609-20. PubMed ID: 23344256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glial Cell Line-Derived Neurotrophic Factor (GDNF) Promotes Angiogenesis through the Demethylation of the Fibromodulin (FMOD) Promoter in Glioblastoma.
    Chen M; Ba H; Lu C; Dai J; Sun J
    Med Sci Monit; 2018 Sep; 24():6137-6143. PubMed ID: 30176167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling tumor invasion: bevacizumab and BMP4 for glioblastoma.
    Rahman M; Azari H; Deleyrolle L; Millette S; Zeng H; Reynolds BA
    Future Oncol; 2013 Sep; 9(9):1389-96. PubMed ID: 23980685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bone morphogenetic protein 4 in the human brain glioma cell line U251.
    Liu B; Tian D; Yi W; Wu L; Cai Q; Dong H; Shen H; Ji B; Wang L; Zhang S; Ruan D; Chen Q
    Cell Biochem Biophys; 2010 Nov; 58(2):91-6. PubMed ID: 20730570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioblastoma cells deficient in DNA-dependent protein kinase are resistant to cell death.
    Chen GG; Sin FL; Leung BC; Ng HK; Poon WS
    J Cell Physiol; 2005 Apr; 203(1):127-32. PubMed ID: 15493013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells.
    Wang G; Rong J; Zhou Z; Duo J
    Mol Biol (Mosk); 2010; 44(6):1010-7. PubMed ID: 21287809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP4 inhibits glioblastoma invasion by promoting E-cadherin and claudin expression.
    Zhao X; Sun Q; Dou C; Chen Q; Liu B
    Front Biosci (Landmark Ed); 2019 Mar; 24(6):1060-1070. PubMed ID: 30844730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GDNF/GFRA1 signaling contributes to chemo- and radioresistance in glioblastoma.
    Avenel ICN; Ewald JD; Ariey-Bonnet J; Kristensen IH; Petterson SA; Thesbjerg MN; Burton M; Thomassen M; Wennerberg K; Michaelsen SR; Kristensen BW
    Sci Rep; 2024 Jul; 14(1):17639. PubMed ID: 39085346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo evaluations of the tyrosine kinase inhibitor NSC 680410 against human leukemia and glioblastoma cell lines.
    Avramis IA; Christodoulopoulos G; Suzuki A; Laug WE; Gonzalez-Gomez I; McNamara G; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):479-89. PubMed ID: 12451475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth-Inhibitory Activity of Bone Morphogenetic Protein 4 in Human Glioblastoma Cell Lines Is Heterogeneous and Dependent on Reduced SOX2 Expression.
    Dalmo E; Johansson P; Niklasson M; Gustavsson I; Nelander S; Westermark B
    Mol Cancer Res; 2020 Jul; 18(7):981-991. PubMed ID: 32234828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme.
    Chu SH; Ma YB; Feng DF; Li ZQ; Jiang PC
    Mol Med Rep; 2013 Jan; 7(1):139-43. PubMed ID: 23076250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glial cell line-derived neurotrophic factor promotes invasive behaviour in testicular seminoma cells.
    Ferranti F; Muciaccia B; Ricci G; Dovere L; Canipari R; Magliocca F; Stefanini M; Catizone A; Vicini E
    Int J Androl; 2012 Oct; 35(5):758-68. PubMed ID: 22519471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRIG1 improves chemosensitivity through inhibition of BCL-2 and MnSOD in glioblastoma.
    Ding J; Liu B; He Y; Yuan X; Tian D; Ji B; Wang L; Wu L; Dong H; Wang J; Zhu X; Cai Q; Zhang S; Chen Q
    Cell Biochem Biophys; 2015 Jan; 71(1):27-33. PubMed ID: 25449296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines.
    Podolski-Renić A; Andelković T; Banković J; Tanić N; Ruždijić S; Pešić M
    Biomed Pharmacother; 2011 Aug; 65(5):345-53. PubMed ID: 21775090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling of glial cell line-derived neurotrophic factor and its receptor GFRα1 induce Nurr1 and Pitx3 to promote survival of grafted midbrain-derived neural stem cells in a rat model of Parkinson disease.
    Lei Z; Jiang Y; Li T; Zhu J; Zeng S
    J Neuropathol Exp Neurol; 2011 Sep; 70(9):736-47. PubMed ID: 21865882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance-related phenotype and apoptosis-related protein expression in ovarian serous carcinomas.
    Yakirevich E; Sabo E; Naroditsky I; Sova Y; Lavie O; Resnick MB
    Gynecol Oncol; 2006 Jan; 100(1):152-9. PubMed ID: 16198399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cell line-derived neurotrophic factor influences proliferation of osteoblastic cells.
    Gale Z; Cooper PR; Scheven BA
    Cytokine; 2012 Feb; 57(2):276-81. PubMed ID: 22142702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers.
    Ito Y; Okada Y; Sato M; Sawai H; Funahashi H; Murase T; Hayakawa T; Manabe T
    Surgery; 2005 Oct; 138(4):788-94. PubMed ID: 16269310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.